T 2059/13 (Aripiprazole against bipolar disorder/OTSUKA) of 07.12.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T205913.20151207
- Date of decision
- 7 December 2015
- Case number
- T 2059/13
- Petition for review of
- -
- Application number
- 06015782.3
- IPC class
- A61K 45/06A61P 25/24A61P 25/18A61P 25/28A61K 31/00A61P 3/04A61P 25/06A61K 31/496A61P 1/08A61P 25/16A61P 25/30A61P 15/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists for the treatment of bipolar disorder
- Applicant name
- OTSUKA PHARMACEUTICAL CO., LTD.
- Opponent name
- STADA Arzneimittel AG
Sanovel Ilaç Sanayi ve Ticaret A.S.
Hexal AG
Teva Pharmaceutical Industries Ltd.
Actavis Group PTC EHF
PENTAFARMA S.A.
CHEMO IBERICA, S.A.
Helm AG - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)Rules of procedure of the Boards of Appeal Art 13(1)
- Keywords
- Late-filed documents - admitted (no)
Sufficiency of disclosure of further medical use - (no) - Catchword
- -
Order
For these reasons it is decided that:
The appeal is dismissed.